polyethylene glycol 3350 powder, for solution
ani pharmaceuticals, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - osmotic laxative if you have kidney disease, except under the advice and supervision of a doctor taking a prescription drug
polyethylene glycol 3350 powder, for solution
bryant ranch prepack - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - osmotic laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days
polyethylene glycol 3350 powder, for solution
bluepoint laboratories - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - osmotic laxative • relieves occasional constipation (irregularity) • generally produces a bowel movement in 1 to 3 days if you have kidney disease, except under the advice and supervision of a doctor • nausea, vomiting or abdominal pain • a sudden change in bowel habits that lasts over 2 weeks • irritable bowel syndrome taking a prescription drug • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. these may be signs of a serious condition. • you get diarrhea • you need to use a laxative for longer than 1 week
peg-3350 and electrolytes- polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium ch
a-s medication solutions - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium cation - unii:lyr4m0nh37, sulfate ion - unii:7is9n8kpmg), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q3 - peg-3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. peg-3350 and electrolytes for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precautions ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to any component of peg-3350 and electrolytes for oral solution [see warnings and precautions ( 5.8)] animal reproduction studies have not been conducted with peg-3350 and electrolytes for oral solution. it is also not known whether peg-3350 and electrolytes for oral solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. peg-3350 and electrolytes for oral solution should be given to a pregnant woman only if clearly nee
moviprep- polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid kit
physicians total care, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 100 g in 1 l - moviprep® is indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. moviprep is contraindicated in patients who have had a severe hypersensitivity reaction to any of its components. pregnancy category c. animal reproduction studies have not been performed with moviprep. it is also not known if moviprep can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. moviprep should be given to a pregnant woman only if clearly needed. because many drugs are excreted in human milk, caution should be exercised when moviprep is administered to a nursing woman. the safety and effectiveness of moviprep in pediatric patients has not been established. of the 413 patients in clinical studies receiving moviprep, 91 (22%) patients were aged 65 or older, while 25 (6%) patients were over 75 years of age. no overall differences in safety or effectiveness were observed between geriatric patients and younger patients, and other repo
trilyte with flavor packs polyethylene glycol 3350 sodium chloride bicarbonate and potassium powder for solution
alaven pharmaceutical llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 420 g in 4 l
colyte with flavor packs polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate powder for solution
alaven pharmaceutical llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 240 g in 4 l
colyte polyethylene glycol 3350 sodium chloride potassium bicarbonate and sulfate anhydrous powder for solution
alaven pharmaceutical llc - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 227.1 g in 3.785 l
miralax- polyethylene glycol 3350 powder, for solution
bayer healthcare llc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g - osmotic laxative osmotic laxative - relieves occasional constipation (irregularity) - generally produces a bowel movement in 1 to 3 days
clear laxative polyethylene glycol 3350 powder for solution
cvs pharmacy - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p) - polyethylene glycol 3350 17 g in 17 g